Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$849K Hold
7,054
0.48% 54
2025
Q4
$743K Hold
7,054
0.4% 53
2025
Q3
$592K Hold
7,054
0.33% 59
2025
Q2
$558K Sell
7,054
-80
-1% -$6.36K 0.33% 61
2025
Q1
$640K Hold
7,134
0.41% 54
2024
Q4
$710K Sell
7,134
-75
-1% -$7.73K 0.46% 48
2024
Q3
$819K Sell
7,209
-100
-1% -$11.9K 0.5% 48
2024
Q2
$905K Hold
7,309
0.57% 45
2024
Q1
$964K Hold
7,309
0.58% 44
2023
Q4
$797K Buy
+7,309
New +$759K 0.5% 52

Other funds holding MRK

Cetera Trust Company's MRK Position: Q1 2026 in Review

Cetera Trust Company held its Merck (MRK) position steady in Q1 2026 at 7,054 shares worth $849K. The position accounts for 0.48% of the portfolio, ranked #54.

Cetera Trust Company first reported a position in MRK in Q4 2023 and has held it in 10 quarters since. The position peaked at $964K in Q1 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Cetera Trust Company held 7,054 shares of Merck worth $849K as of Q1 2026.
  • Cetera Trust Company left its Merck share count unchanged in Q1 2026.
  • Merck made up 0.48% of Cetera Trust Company's portfolio in Q1 2026, its #54 holding.
  • Cetera Trust Company first reported a position in Merck in Q4 2023 and has held it in 10 quarters since.
  • Cetera Trust Company's Merck position peaked at $964K in Q1 2024.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Cetera Trust Company's 13F filing for Q1 2026, filed 8 May 2026.